Meningitis, Cryptococcal: Clinical Trials

7 trials for Meningitis, Cryptococcal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 7
Phase 12Completed 2

Follow Meningitis, Cryptococcal: new trials by email Literature Review of Meningitis, Cryptococcal trials Research Report on Meningitis, Cryptococcal

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis
AMBITION trial control, Flucytosine - Cryptococcal Meningitis
Phase 2CompletedUniversity of Minnesota482024-04-092025-08-27
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT)
MAT2203, Amphotericin B - Cryptococcal Meningitis
Phase 1 / Phase 2CompletedMatinas BioPharma Nanotechnologies, Inc.1782019-10-242023-03-31
Treatment With Tamoxifen in Cryptococcal Meningitis
Tamoxifen, Amphotericin B, Fluconazole - Meningitis Streptococcal, Hiv
Phase 2CompletedOxford University Clinical Research Unit, Vietnam502017-10-102019-12-02
High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
Fluconazole, Amphotericin B - Cryptococcal Meningitis, HIV Infections
Phase 1 / Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1682010-04-162021-11-04
Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis
Amphotericin B, Fluconazole - Cryptococcal Meningitis
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1432005-05-012012-05-16
Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis
Itraconazole, Flucytosine, Fluconazole - Meningitis, Cryptococcal, HIV Infections
Phase 2CompletedInterMune602000-01-012009-06-03
Dexamethasone in Cryptococcal Meningitis
Flucytosine, Fluconazole, Amphotericin B - Meningitis, Cryptococcal, HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)362021-10-28

Narrower conditions

HIV Infections (4)  ·  Meningitis (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Cryptococcosis (2)  ·  AIDS-Related Opportunistic Infections (1)  ·  Bacterial Infections (1)  ·  Brain Diseases (1)  ·  Meningoencephalitis (1)

Broader conditions

Bacterial Infections and Mycoses (7)  ·  Central Nervous System Diseases (7)  ·  Central Nervous System Fungal Infections (7)  ·  Central Nervous System Infections (7)  ·  Infections (7)  ·  Meningitis, Fungal (7)  ·  Mycoses (7)  ·  Nervous System Diseases (7)  ·  Neuroinflammatory Diseases (7)  ·  Blood-Borne Infections (5)  ·  Communicable Diseases (5)  ·  Cryptococcosis (5)  ·  Genital Diseases (5)  ·  Immune System Diseases (5)  ·  Immunologic Deficiency Syndromes (5)

Interventions

Amphotericin B (6)  ·  Fluconazole (5)  ·  Flucytosine (3)  ·  Dexamethasone (1)  ·  Itraconazole (1)  ·  Tamoxifen (1)  ·  amphotericin B, deoxycholate drug combination (1)  ·  interferon gamma-1b (1)  ·  liposomal amphotericin B (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  InterMune (1)  ·  Matinas BioPharma Nanotechnologies, Inc. (1)  ·  Oxford University Clinical Research Unit, Vietnam (1)  ·  University of Minnesota (1)

Countries

United States (4)  ·  Uganda (3)  ·  Peru (2)  ·  Thailand (2)  ·  India (1)  ·  Kenya (1)  ·  Puerto Rico (1)  ·  South Africa (1)  ·  Vietnam (1)  ·  Zimbabwe (1)

Top investigators

David B Meya (1)  ·  David R Boulware (1)  ·  J Jacobson (1)  ·  Jeremy Day, MD (1)  ·  Robert A. Larsen, MD (1)  ·  Umesh G. Lalloo, MD, FRCP (1)

Results publications

PMID 19441980, PMID 19897055, PMID 30801037, PMID 32747357, PMID 34581270, PMID 36780493, PMID 37606364, PMID 38943665, PMID 39972326, PMID 40665233, PMID 40795226